Johnson & Johnson Acquires Numab’s Investigational Antibody for the Treatment of Atopic Dermatitis

Posted on by admin
1 min read

The acquisition of a novel therapy for atopic dermatitis includes an all-cash transaction totaling approximately $1.25 billion.

Avatar for admin
admin https://goorre.com

You May Also Like

More From Author

+ There are no comments

Add yours